These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 35988663)

  • 41. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.
    Dillon JA; Li H; Sealy J; Ruben M; Prabhakar P;
    Sex Transm Dis; 2001 Sep; 28(9):508-14. PubMed ID: 11518867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of genome sequencing to resolve differences in gradient diffusion and agar dilution antimicrobial susceptibility testing performance of
    Ma A; Ferrato C; Martin I; Smyczek P; Gratrix J; Dingle TC
    J Clin Microbiol; 2023 Nov; 61(11):e0060623. PubMed ID: 37882549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emergence and Genomic Characterization of Neisseria gonorrhoeae Isolates with High Levels of Ceftriaxone and Azithromycin Resistance in Guangdong, China, from 2016 to 2019.
    Lin X; Chen W; Yu Y; Lan Y; Xie Q; Liao Y; Wu X; Tang S; Qin X; Zheng H
    Microbiol Spectr; 2022 Dec; 10(6):e0157022. PubMed ID: 36377922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
    Jacobsson S; Cole MJ; Spiteri G; Day M; Unemo M;
    BMC Infect Dis; 2021 Mar; 21(1):273. PubMed ID: 33736608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extensively drug-resistant (XDR)
    Pleininger S; Indra A; Golparian D; Heger F; Schindler S; Jacobsson S; Heidler S; Unemo M
    Euro Surveill; 2022 Jun; 27(24):. PubMed ID: 35713023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance study.
    Golparian D; Cole MJ; Sánchez-Busó L; Day M; Jacobsson S; Uthayakumaran T; Abad R; Bercot B; Caugant DA; Heuer D; Jansen K; Pleininger S; Stefanelli P; Aanensen DM; Bluemel B; Unemo M;
    Lancet Microbe; 2024 May; 5(5):e478-e488. PubMed ID: 38614111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emergence of a predominant sequence type ST7363 and the increasing trend of resistance to cefixime and ceftriaxone in Neisseria gonorrhoeae in Southern Taiwan, 2019-2021.
    Lin HH; Li JW; Yang TY; Lee CY; Jain SH; Lin SY; Lu PL
    J Microbiol Immunol Infect; 2023 Aug; 56(4):833-841. PubMed ID: 37002111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
    Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
    APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Susceptibility of Neisseria gonorrhoeae against a dual treatment antibiotics regimen in primary health centres in Surabaya, Indonesia.
    Hidayati AN; Sawitri ; Rositawati A; Wardhani PH; Bintanjoyo L
    Aust J Gen Pract; 2024 Jul; 53(7):499-503. PubMed ID: 38959520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011.
    Thakur SD; Araya P; Borthagaray G; Galarza P; Hernandez AL; Payares D; Sanabria Cruz OM; Carvallo ME; Corredor AH; Dillon JR
    Sex Transm Dis; 2017 Mar; 44(3):157-160. PubMed ID: 28178114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial resistance of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Urban Hospitals, Lusaka, Zambia.
    Sarenje KL; Ngalamika O; Maimbolwa MC; Siame A; Munsaka SM; Kwenda G
    BMC Infect Dis; 2022 Aug; 22(1):688. PubMed ID: 35962370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins.
    Regnath T; Mertes T; Ignatius R
    Euro Surveill; 2016 Sep; 21(36):. PubMed ID: 27632642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emergence of high-level azithromycin-resistant
    Müller EE; Gumede LYE; Maseko DV; Mahlangu MP; Venter JME; Da Costa Dias B; Nhlapho D; Kularatne RS
    Sex Health; 2024 Feb; 21(1):NULL. PubMed ID: 38029797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of antimicrobial resistance in <5 h in Neisseria gonorrhoeae isolates using flow cytometry-proof of concept for seven clinically relevant antimicrobials.
    Somajo S; Nilsson F; Ekelund O; Unemo M
    J Antimicrob Chemother; 2024 Apr; 79(4):815-819. PubMed ID: 38334417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seven Years of Culture Collection of
    Carannante A; Vacca P; Fontana S; Dal Conte I; Ghisetti V; Cusini M; Prignano G; Vocale C; Barbui AM; Stroppiana E; Busetti M; Mencacci A; Rotondi M; De Francesco MA; Bonanno CL; Innocenti P; Latino MA; Riccobono E; Poletti F; Casonato IC; Soldato G; Ambrosio L; Boros S; Ciammaruconi A; Lista F; Stefanelli P
    Microb Drug Resist; 2023 Mar; 29(3):85-95. PubMed ID: 36757312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
    Cole MJ; Spiteri G; Chisholm SA; Hoffmann S; Ison CA; Unemo M; Van de Laar M
    Euro Surveill; 2014 Nov; 19(45):20955. PubMed ID: 25411689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.
    Kubanova A; Kubanov A; Frigo N; Solomka V; Semina V; Vorobyev D; Khairullin R; Unemo M
    BMC Infect Dis; 2014 Jun; 14():342. PubMed ID: 24947981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
    Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
    J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genotypic and Phenotypic Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae: a Cross-Sectional Study of Isolates Recovered from Routine Urine Cultures in a High-Incidence Setting.
    Bailey AL; Potter RF; Wallace MA; Johnson C; Dantas G; Burnham CA
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31341071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.